The DOI matches its Crossref record.
Review article: omega‐3 fatty acids – a promising novel therapy for non‐alcoholic fatty liver disease
Abstract
Aliment Pharmacol Ther 31, 679–692 Summary: Background Non‐alcoholic fatty liver disease affects 10–35% of the adult population worldwide; there is no consensus on its treatment. Omega‐3 fatty acids have proven benefits for hyperlipidaemia and cardiovascular disease, and have recently been suggested as a treatment for non‐alcoholic fatty liver disease. Aims To review the evidence base for omega‐3 fatty acids in non‐alcoholic fatty liver disease and critically appraise the literature relating to human trials. Methods A Medline and PubMed search was performed to identify relevant literature using search terms ‘omega‐3’, ‘N‐3 PUFA’, ‘eicosapentaenoic acid’, ‘docosahexaenoic acid’, ‘non‐alcoholic fatty liver disease’ and ‘NAFLD’. Results Omega‐3 fatty acids are important regulators of hepatic gene transcription. Animal studies demonstrate that they reduce hepatic steatosis, improve insulin sensitivity and reduce markers of inflammation. Clinical trials in human subjects generally confirm these findings, but have significant design inadequacies. Conclusions Omega‐3 fatty acids are a promising treatment for non‐alcoholic fatty liver disease which require to be tested in randomized placebo‐controlled trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 134
- 10.1016/S1665-2681(19)31820-4 · DOI · Paper page
- 10.1097/00004836-200203000-00013 · DOI · Paper page
- 10.1002/hep.510240410 · DOI
- 10.1016/S0140-6736(05)67402-8 · DOI · Paper page
- Prashanth M, 2009, Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus, J Assoc Physicians India, 57, 205
- 10.1111/j.1440-1746.2006.04781.x · DOI · Paper page
- 10.2337/diabetes.54.11.3140 · DOI · Paper page
- 10.3748/wjg.v13.i10.1579 · DOI · Paper page
- 10.1111/j.1572-0241.2008.02034.x · DOI · Paper page
- 10.1016/S0016-5085(98)70599-2 · DOI · Paper page
- 10.1002/hep.21763 · DOI · Paper page
- 10.1016/j.mam.2007.09.014 · DOI
- 10.1111/j.1749-6632.1999.tb07793.x · DOI · Paper page
- 10.1097/MOG.0b013e3282fbccf2 · DOI · Paper page
- 10.1172/JCI200319246 · DOI · Paper page
- 10.1530/eje.1.01821 · DOI · Paper page
- 10.1038/nri1937 · DOI · Paper page
- 10.1097/MCG.0b013e31815e4079 · DOI
- 10.1016/j.jhep.2007.06.020 · DOI · Paper page
- 10.1016/j.mehy.2008.07.008 · DOI
- 10.1592/phco.27.5.715 · DOI
- Jacobson TA, 2006, Secondary prevention of coronary artery disease with omega‐3 fatty acids, Am J Cardiol, 98, 6170, 10.1016/j.amjcard.2005.12.028 · DOI
- 10.1093/ajcn/71.1.224s · DOI · Paper page
- 10.2174/1871520610909040457 · DOI
- 10.1017/S0954422408998620 · DOI
- 10.1007/s12017-008-8036-z · DOI · Paper page
- 10.1159/000074898 · DOI · Paper page
- 10.1097/00075197-200503000-00003 · DOI · Paper page
- 10.1016/j.jhep.2007.08.005 · DOI · Paper page
- 10.1097/01.mcg.0000225515.28536.3a · DOI
- 10.1097/MOL.0b013e3282f2e2a8 · DOI · Paper page
- 10.1016/j.freeradbiomed.2004.06.033 · DOI · Paper page
- 10.1042/CS20030326 · DOI · Paper page
- 10.1016/j.jhep.2007.09.009 · DOI · Paper page
- 10.1097/MOL.0b013e3282ffaf6a · DOI · Paper page
- 10.1161/01.RES.0000127122.22685.0A · DOI · Paper page
- 10.1097/00041433-199912000-00011 · DOI
- 10.1016/j.chemphyslip.2008.02.007 · DOI
- 10.1053/jhep.2003.50307 · DOI · Paper page
- 10.1002/hep.20170 · DOI · Paper page
- 10.1016/S1097-2765(00)80467-0 · DOI · Paper page
- 10.1074/jbc.M306238200 · DOI · Paper page
- 10.1016/j.ejphar.2006.02.028 · DOI · Paper page
- 10.1161/CIRCULATIONAHA.104.475673 · DOI · Paper page
- 10.1210/en.2007-0014 · DOI · Paper page
- 10.1172/JCI0215593 · DOI · Paper page
- 10.1073/pnas.96.22.12737 · DOI · Paper page
- Azzout‐Marniche D, 2000, Insulin effects on sterol regulatory‐element‐binding protein‐1c (SREBP‐1c) transcriptional activity in rat hepatocytes, Biochem J, 350, 389, 10.1042/bj3500389 · DOI · Paper page
- 10.1194/jlr.M500365-JLR200 · DOI · Paper page
- 10.1172/JCI119248 · DOI · Paper page
- 10.1074/jbc.274.50.35840 · DOI · Paper page
- 10.1074/jbc.M105711200 · DOI · Paper page
- 10.1074/jbc.M008973200 · DOI · Paper page
- 10.1074/jbc.274.33.23577 · DOI · Paper page
- 10.1074/jbc.273.40.25537 · DOI · Paper page
- 10.1074/jbc.274.36.25892 · DOI · Paper page
- 10.1152/ajpendo.1996.270.2.E353 · DOI
- 10.1210/en.2003-0479 · DOI
- 10.1146/annurev.nutr.25.051804.101917 · DOI · Paper page
- 10.1146/annurev.cellbio.16.1.459 · DOI · Paper page
- 10.1074/jbc.M307973200 · DOI
- 10.1042/bj20020340 · DOI
- 10.1172/JCI21025 · DOI · Paper page
- Davidson MH, 2006, Mechanisms for the hypotriglyceridemic effect of marine omega‐3 fatty acids.[see comment], Am J Cardiol, 98, 2733, 10.1016/j.amjcard.2005.12.024 · DOI · Paper page
- 10.1172/JCI25256 · DOI · Paper page
- 10.1074/jbc.M601277200 · DOI
- 10.2337/db06-0200 · DOI · Paper page
- 10.1074/jbc.272.43.26827 · DOI · Paper page
- 10.1042/bj3410371 · DOI
- 10.1016/j.plipres.2004.05.004 · DOI · Paper page
- 10.1007/s11745-997-0022-3 · DOI
- 10.1056/NEJM199301283280404 · DOI · Paper page
- 10.1177/0148607100024003159 · DOI
- 10.1007/s11745-005-1443-8 · DOI
- 10.1111/j.1440-1746.2008.05543.x · DOI · Paper page
- 10.1016/j.jhep.2008.10.031 · DOI
- 10.1161/ATVBAHA.106.136853 · DOI · Paper page
- 10.1007/s11745-007-3039-3 · DOI
- 10.1203/01.PDR.0000153672.43030.75 · DOI · Paper page
- 10.1097/01.TP.0000150023.86487.44 · DOI
- 10.1016/j.plefa.2009.02.004 · DOI
- 10.1096/fj.08-125674 · DOI · Paper page
- 10.1016/j.hep.2003.09.028 · DOI · Paper page
- 10.2353/ajpath.2006.050953 · DOI · Paper page
- 10.1002/mnfr.200700315 · DOI
- 10.1111/j.1440-1746.2007.05157.x · DOI · Paper page
- 10.1002/hep.20093 · DOI
- 10.1590/S0100-879X2006000200004 · DOI
- 10.1074/jbc.M004045200 · DOI · Paper page
- 10.1093/jn/132.1.88 · DOI
- 10.1016/S0899-9007(00)00392-0 · DOI
- 10.1006/cimm.1995.1106 · DOI · Paper page
- 10.1007/s00125-005-0053-y · DOI · Paper page
- 10.1111/j.1365-2036.2006.02885.x · DOI · Paper page
- 10.1016/j.dld.2007.10.003 · DOI · Paper page
- 10.1097/MCG.0b013e31815591aa · DOI · Paper page
- 10.1016/S0168-8278(02)00331-8 · DOI · Paper page
- 10.2310/JIM.0b013e318177024d · DOI
- 10.1002/hep.20466 · DOI · Paper page
- 10.1111/j.1365-2036.2007.03246.x · DOI · Paper page
- 10.1053/jhep.2003.50320 · DOI · Paper page
- 10.1111/j.1572-0241.2005.41334.x · DOI · Paper page
- 10.1136/gut.2003.027581 · DOI · Paper page
- 10.1002/hep.23276 · DOI · Paper page
- 10.1111/j.1572-0241.2003.07375.x · DOI
- 10.1002/hep.22575 · DOI · Paper page
- Sabuncu T, 2003, The effects of sibutramine and orlistat on the ultrasonographic findings, insulin resistance and liver enzyme levels in obese patients with non‐alcoholic steatohepatitis, Rom J Gastroenterol, 12, 189
- 10.1111/j.1478-3231.2007.01555.x · DOI
- 10.1002/hep.20251 · DOI · Paper page
- 10.1007/s11695-007-9086-2 · DOI · Paper page
- 10.1016/j.cgh.2008.08.012 · DOI · Paper page
- 10.1111/j.1440-1746.2007.04833.x · DOI · Paper page
- 10.1016/S0140-6736(01)06042-1 · DOI · Paper page
- 10.1111/j.1365-2036.2005.02420.x · DOI · Paper page
- 10.1016/j.clinthera.2008.06.012 · DOI
- 10.1111/j.1572-0241.2005.41583.x · DOI · Paper page
- 10.1111/j.1365-2036.2008.03869.x · DOI · Paper page
- 10.1111/j.1572-0241.2001.03553.x · DOI · Paper page
- 10.1002/hep.1840380427 · DOI · Paper page
- 10.1002/hep.20012 · DOI · Paper page
- 10.1053/j.gastro.2008.03.078 · DOI · Paper page
- 10.1056/NEJMoa060326 · DOI · Paper page
- 10.1046/j.1365-2036.2001.01083.x · DOI · Paper page
- 10.1111/j.1572-0241.2003.08699.x · doi:10.1111/j.1572-0241.2003.08699.x · Paper page
- 10.1053/jhep.2003.50316 · DOI · Paper page
- 10.1016/S0168-8278(02)00441-5 · DOI
- 10.1111/j.1572-0241.2004.40220.x · DOI · Paper page
- 10.1111/j.1572-0241.2004.40064.x · DOI · Paper page
- 10.1002/hep.20092 · DOI · Paper page
- 10.1002/hep.20420 · DOI · Paper page
- 10.3748/wjg.15.942 · DOI · Paper page
- 10.1111/j.1572-0241.2001.04129.x · doi:10.1111/j.1572-0241.2001.04129.x · Paper page
- 10.1046/j.1440-1746.2003.03156.x · DOI
- 10.1007/s10620-006-8030-y · DOI
Cited by
Chalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., Harrison, S. A., Brunt, E. M., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29367 · Cited by 7,239
Chalasani, N., Younossi, Z., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K., Charlton, M., & Sanyal, A. J. (2012) · Hepatology · doi:10.1002/hep.25762 · Cited by 3,803
Chalasani, N., Younossi, Z., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K., Charlton, M., & Sanyal, A. J. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.04.001 · Cited by 1,775
Omega-3 Fatty Acids and Cardiovascular Disease
Mozaffarian, D., & Wu, J. H. Y. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.06.063 · Cited by 1,771
Chalasani, N., Younossi, Z., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K., Charlton, M., & Sanyal, A. J. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.128 · Cited by 585
Metadata
- Authors
- MASTERTON, G. S., PLEVRIS, J. N., & HAYES, P. C.
- Venue
- Alimentary Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2010-03
- Volume
- 31
- Issue
- 7
- Pages
- 679-692
- ISSN
- 0269-2813 (ISSN-L)
- 1365-2036
- OpenAlex
- W2616752079
- Cited by
- 164
- References
- 0
- FWCI
- 9.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Review article: omega‐3 fatty acids – a promising novel therapy for non‐alcoholic fatty liver disease. https://app.cochat.ai/papers/10.1111/j.1365-2036.2009.04230.x
- The paper
- MASTERTON, G. S., PLEVRIS, J. N., & HAYES, P. C. (2010). Review article: omega‐3 fatty acids – a promising novel therapy for non‐alcoholic fatty liver disease. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/j.1365-2036.2009.04230.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.